Completed PHASE4 INTERVENTIONAL 4-arm NCT02161653

Metadoxine as a Therapy for Severe Alcoholic Hepatitis

Impact of Metadoxine in the Oxidative Stress and Early Mortality in Patients With Severe Alcoholic Hepatitis

Sponsor: Hospital General de Mexico

Interventions Pentoxifylline plus Metadoxine Prednisone plus Metadoxine

Updated 5 times since 2017 Last updated: Nov 8, 2014 Started: Apr 30, 2010 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Severe Alcoholic Hepatitis and is currently completed. Hospital General de Mexico leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital General de Mexico

Data source: Hospital General de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico